Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868293 · ClinicalTrials.gov registry record · NA
Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial
A NA study of Drug Resistant Epilepsy, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03868293: Recruiting NA study of Drug Resistant Epilepsy, sponsored by Brigham and Women's Hospital.
NCT03868293 is a NA study of Drug Resistant Epilepsy that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants, below the 35-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03868293, a NA study of Drug Resistant Epilepsy, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the proposed pilot study is to investigate patient tolerability and efficacy of moderate term, repeated exposure of Pulsed Low-Intensity Focused Ultrasound (PLIFUS) in patients with drug-resistant temporal lobe epilepsy.
Primary Outcome
The aim of the proposed pilot study is to investigate patient tolerability of moderate term, repeated exposure of Pulsed Low-Intensity Focused Ultrasound (PLIFUS) in patients with drug-resistant temporal lobe epilepsy. We hypothesize that the treatments will be well-tolerated, without adverse events.
Conditions Studied
Interventions
- DEVICE Focused ultrasound
Study Locations (1)
Massachusetts
- Brigham and women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2026-03-09 |
| Phase | NA |
What NCT03868293 shows while recruiting
NCT03868293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 35-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Drug Resistant Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Focused ultrasound is the first listed.
NCT03868293 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03868293 about?
NCT03868293 is a clinical study titled "Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial". The aim of the proposed pilot study is to investigate patient tolerability and efficacy of moderate term, repeated exposure of Pulsed Low-Intensity Focused Ultrasound (PLIFUS) in patients with drug-resistant temporal lobe epilepsy.
What is the current status of trial NCT03868293?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2019-02-07. Estimated completion is 2026-03-09.
What conditions does trial NCT03868293 study?
This clinical trial studies the following conditions: Drug Resistant Epilepsy.
What interventions are being tested in trial NCT03868293?
The interventions under investigation include: Focused ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03868293?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03868293 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Resistant Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infrared Photobiomodulation in Humans With Epilepsy
RECRUITING · NA
-
Goals for Epilepsy Clinic Visits Trial
RECRUITING · NA
-
Novel Helmet Design in Patients With Seizures
COMPLETED · NA
-
Electrophysiologic Studies of Cognition in Epilepsy Patients
COMPLETED · NA
-
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
RECRUITING · Phase 2
-
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI